1 |
Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, et al. : The whole-genome landscape of medulloblastoma subtypes. Nature 547 : 311-317, 2017
DOI
|
2 |
Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, et al. : Subgroup specific structural variation across 1,000 medulloblastoma genomes. Nature 488 : 49-56, 2012
DOI
|
3 |
Patterson E, Farr RF : Cerebellar medulloblastoma: treated by irradiation of the whole central nervous system. Acta Radiol 39 : 323-336, 1953
DOI
|
4 |
Sturm D, Bender S, Jones DT, Lichter P, Grill J, Becher O, et al. : Pediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 14 : 92-107, 2014
DOI
|
5 |
Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, et al. : Integrated (epi)-Genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors. Cancer Cell 30 : 891-908, 2016
DOI
|
6 |
Torchia J, Picard D, Lafay-Cousin L, Hawkins CE, Kim SK, Letourneau L, et al. : Molecular subgroups of atypical teratoid rhabdoid tumors in children: an integrated genomic and clinicopathological analysis. Lancet Oncol 16 : 569-582, 2015
DOI
|
7 |
Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, et al. : Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20 : 143-157, 2011
DOI
|
8 |
Zhou Z, Singh R, Souweidane MM : Convection-enhanced delivery for diffuse intrinsic pontine glioma treatment. Curr Neuropharmacol 15 : 116-128, 2017
|
9 |
Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B : Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59 : 74-79, 1999
|
10 |
Alli S, Figueiredo CA, Golbourn B, Sabha N, Yijun M, Bondoc A, et al. : Brainstem blood brain barrier disruption using focused ultrasound. J Control Release, 2018, under revision
|
11 |
Biggs PU, Garen PD, Powers JM, Garvin AJ : Malignant rhabdoid tumor of the central nervous system. Hum Pathol 18 : 332-327, 1987
DOI
|
12 |
Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, et al. : Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31 : 737-754.e6, 2017
DOI
|
13 |
Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, et al. : Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7 : 813-820, 2006
DOI
|
14 |
Morrissy AS, Cavalli FMG, Remke M, Ramaswamy V, Shih DJH, Holgado BL, et al. : Spatial heterogeneity in medulloblastoma. Nat Genet 49 : 780-788, 2017
DOI
|
15 |
Gomez S, Garrido-Garcia A, Garcia-Gerique L, Lemos I, Sunol M, de Torres C, et al. : A novel method for rapid molecular subgrouping of medulloblastoma. Clin Cancer Res 24 : 1355-1363, 2018
DOI
|
16 |
Guerreiro Stucklin AS, Ramaswamy V, Daniels C, Taylor MD : Review of molecular classication and treatment implications of pediatric brain tumors. Curr Opin Pediatr 30 : 3-9, 2018
DOI
|
17 |
Korshunov A, Ryzhova M, Hovestadt V, Bender S, Sturm D, Capper D, et al. : Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol 129 : 669-678, 2015
DOI
|
18 |
Mack SC, Pajtler KW, Chavez L, Okonechnikov K, Bertrand KC, Wang X, et al. : Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature 553 : 101-105, 2018
|
19 |
Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stutz AM, et al. : Epig enomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 506 : 445-450, 2014
DOI
|
20 |
Muller M, Hubbard SL, Provias J, Greenberg M, Becker LE, Rutka JT : Malignant rhabdoid tumour of the pineal region. Can J Neurol Sci 21 : 273-277, 1994
DOI
|